(Q54817202)

English

D283 Med

cell line

D283 MED
D283-MED
D283_Med
D-283 Med
D-283 Med-C
D-283MED
D283MED
D-283
D283
Med 283
H283

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

13 July 2024

cancer cell line

1 reference

Cellosaurus release 49

13 July 2024

described by source

Medulloblastoma cell-substrate interaction in vitro

1 reference

Cellosaurus release 49

13 July 2024

A rapidly dividing human medulloblastoma cell line (D283 MED) expresses all three neurofilament subunits

1 reference

Cellosaurus release 49

13 July 2024

Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med.

1 reference

Cellosaurus release 49

13 July 2024

Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles

1 reference

Cellosaurus release 49

13 July 2024

Hypercalcaemia in relapsed medulloblastoma 8 years post-diagnosis; evidence to support PTHrP production by medulloblastoma cells

1 reference

Cellosaurus release 49

13 July 2024

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers

1 reference

Cellosaurus release 49

13 July 2024

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

Cellosaurus release 49

13 July 2024

PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas

1 reference

Cellosaurus release 49

13 July 2024

A landscape of pharmacogenomic interactions in cancer.

1 reference

Cellosaurus release 49

13 July 2024

Signatures of mutation and selection in the cancer genome

1 reference

Cellosaurus release 49

13 July 2024

Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma

1 reference

Cellosaurus release 49

13 July 2024

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

1 reference

Cellosaurus release 49

13 July 2024

BET bromodomain inhibition of MYC-amplified medulloblastoma.

1 reference

Cellosaurus release 49

13 July 2024

In vitro models of medulloblastoma: Choosing the right tool for the job

1 reference

Cellosaurus release 49

13 July 2024

Data on the number and frequency of scientific literature citations for established medulloblastoma cell lines

1 reference

Cellosaurus release 49

13 July 2024

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 49

13 July 2024

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 49

13 July 2024

Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like Phenotype

1 reference

Cellosaurus release 49

13 July 2024

Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts

1 reference

Cellosaurus release 49

13 July 2024

established from medical condition

medulloblastoma

1 reference

Cellosaurus release 44

7 January 2023

medulloblastoma non-WNT/non-SHH group 3

1 reference

Cellosaurus release 49

13 July 2024

derived from organism type

1 reference

Cellosaurus release 49

13 July 2024

http://purl.obolibrary.org/obo/BTO_0005135

1 reference

Cellosaurus release 49

13 July 2024

http://purl.obolibrary.org/obo/EFO_0002156

1 reference

Cellosaurus release 49

13 July 2024

http://purl.obolibrary.org/obo/CLO_0002673

1 reference

Cellosaurus release 49

13 July 2024

Identifiers

Cell Line Ontology ID

1 reference

Cellosaurus release 49

13 July 2024

1 reference

Cellosaurus release 49

13 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54817202&oldid=2202957983"